The Conference Forum announces the 14th annual PODD Drug
Delivery Conference's 2024 keynotes and plenary sessions.
NEW
YORK, July 2, 2024 /PRNewswire-PRWeb/
-- The Conference Forum announces the keynotes and plenary
sessions for the 14th annual PODD: Partnership Opportunities in
Drug Delivery conference, which will take place on October 28-29 at the Westin Copley Place in
Boston, MA.
"Annually, the PODD conference brings
together the drug delivery community, spanning participants from
big pharma, biotech and technology providers, and in doing so
provides a truly unique two-day program of partnering and cutting
edge drug delivery science," said Stephen
Buckley, Novo Nordisk
The PODD Conference fosters collaborations between
pharmaceutical, biotech and drug delivery companies to develop more
effective therapies for patients, improve the patient experience of
taking medicine and extend the life cycle of the medicine.
"Annually, the PODD conference brings together the drug delivery
community, spanning participants from big pharma, biotech and
technology providers, and in doing so provides a truly unique
two-day program of partnering and cutting edge drug delivery
science," said Stephen Buckley,
Scientific Vice President, Novo
Nordisk. "A must-have fixture on my calendar year in, year
out."
The PODD 2023 keynotes and featured speakers include:
MIT's Dr Robert Langer, a pioneer in the research and
development of drug delivery technology, will be joined by Johnson
& Johnson's Dr Richard Tillyer
to discuss designing novel drug delivery systems for continuous,
precise and controlled release of medications.
Dr Laura Sepp-Lorenzino, a leader
in neurological R&D and CSO of Intellia Therapeutics, is the
Gene Delivery Keynote. Dr Sepp-Lorenzino will present on the
evolution of delivery approaches for in vivo gene editing to
achieve meaningful clinical impact.
Dr Anand Subramony, Vice
President, Drug Delivery, Device, Connected Solutions &
Innovation, Eli Lilly & Company, will join the PODD Conference
as the GLP-1 Zeitgeist. Dr Subramony will present on the
re-emergence of drug delivery facilitated by the disruption effects
of GLP-1 drugs and nucleic acid modalities.
Mark Simon of Stifel, Dr
Gail Ryan of Point32Health, and Dr
Michael Sherman of RA Ventures will
come together for the Payer Perspectives on Drug Delivery panel to
discuss the future of weight loss drugs and GLP-1s, shifts in how
self-insured employers consider drug coverage based on cost, and
potential factors influencing market access for gene therapies for
more common conditions.
Additional topic areas for 2023 include: Ex-liver delivery of
RNA/DNA; developing self administration of subcutaneous
therapeutics; AI approaches to cell & gene delivery; improving
bioavailability and stability through excipient innovation;
designing and developing drug delivery for LMICs; achieving oral
delivery of peptides; vaccine delivery innovations; focused
ultrasound delivery for CNS; sustained release innovations;
translating digital health from the clinical to commercialization;
balancing between concentration and volume for patient-centric
biologics; and biomaterial implants.
"We are proud to connect industry leaders and innovators to
discuss and understand how to advance the design and development of
drug delivery systems and devices to improve patient lives," said
Andrew Goldstein, Senior Conference
Producer for the PODD Conference.
Pharmaceutical companies presenting include: Amgen, Astellas
Pharma, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb,
Chiesi USA, Eli Lilly &
Company, EMD Serono, Genentech, Gilead Sciences, GSK, Intellia
Therapeutics, Ionis Pharmaceuticals, Johnson & Johnson, Merck
& Co, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche, Sanofi,
Sun Pharma and Takeda.
To learn more about the event, visit PODDConference.com
About the PODD: Partnership Opportunities in Drug Delivery
Conference
Pharma, biotech and the drug delivery industries gather annually at
PODD to assess delivery needs, latest trends and information on
deals, and learn about a wide range of innovative drug delivery
technologies that could improve the delivery of various types of
drugs. This can include proteins, peptides, oligonucleotides,
biologics, small molecules and more. PODD provides business
development opportunities through organized networking and a
partnering tool for new, emerging and established
collaborations.
About the Conference Forum
The Conference Forum is a life science industry research firm
that develops conferences, podcasts, newsletters and webinars
primarily around how to get therapeutics to patients faster. They
examine and challenge the complex ecosystem of drug development and
delivery, bringing ideas together from a variety of sources to help
advance clinical research with common goals that are
patient-focused. They are committed to creating the best content,
promoting the exchange of ideas and solutions among peers, and
providing high-quality networking.
Learn more about the Conference Forum at
theconferenceforum.org
Media Contact
Andrew Goldstein, PODD
Conference, (646) 290-8449, service@tcfllc.org,
https://poddconference.com/
View original
content:https://www.prweb.com/releases/podd-drug-delivery-conference-announces-2024-keynotes-and-agenda-302185787.html
SOURCE PODD Conference